FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1510098440> ?p ?o ?g. }

• W1510098440 endingPage "1804" @default.
• W1510098440 startingPage "1798" @default.
• W1510098440 abstract "Studies by various investigators have demonstrated that the low Km, cAMP-specific phosphodiesterase (PDE IV) is selectively inhibited by a group of compounds typified by rolipram and Ro 20-1724. In addition to inhibiting the catalytic activity of PDE IV, rolipram binds to a high affinity binding site present in brain homogenates. Although it has been assumed that the high affinity rolipram-binding site is PDE IV, no direct evidence has been produced to support this assumption. The present studies were undertaken to determine whether the rolipram-binding site is coexpressed with PDE IV catalytic activity in Saccharomyces cerevisiae genetically engineered to express human recombinant monocytic PDE IV (hPDE IV). Expressing hPDE IV cDNA in yeast resulted in a 20-fold increase in PDE activity that was evident within 1 h of induction and reached a maximum by 3-6 h. The recombinant protein represented hPDE IV as judged by its immunoreactivity, molecular mass (approximately 88 kDa), kinetic characteristics (cAMP Km = 3.1 microM; cGMP Km greater than 100 microM), sensitivity to rolipram (Ki = 0.06 microM), and insensitivity to siguazodan (PDE III inhibitor) and zaprinast (PDE V inhibitor). Saturable, high affinity [3H] (R)-rolipram-binding sites (Kd = 1.0 nM) were coexpressed with PDE activity, indicating that both binding activity and catalytic activity are properties of the same protein. A limited number of compounds were tested for their ability to inhibit hPDE IV catalytic activity and compete for [3H](R)-rolipram binding. Analysis of the data revealed little correlation (r2 = 0.35) in the structure-activity relationships for hPDE IV inhibition versus competition for [3H] (R)-rolipram binding. In fact, certain compounds (e.g. (R)-rolipram Ro 20-1724) possessed a 10-100-fold selectivity for inhibition of [3H] (R)-rolipram binding over hPDE IV inhibition, whereas others (e.g. dipyridamole, trequinsin) possessed a 10-fold selectivity for PDE inhibition. Thus, although the results of these studies demonstrate that hPDE IV activity and high affinity [3H](R)-rolipram binding are properties of the same protein, they do not provide clear cut evidence linking the binding site with the PDE inhibitory activity of rolipram and related compounds." @default.
• W1510098440 created "2016-06-24" @default.
• W1510098440 creator A5025569634 @default.
• W1510098440 creator A5035784306 @default.
• W1510098440 creator A5039465261 @default.
• W1510098440 creator A5043712059 @default.
• W1510098440 creator A5053977112 @default.
• W1510098440 creator A5076338826 @default.
• W1510098440 creator A5078695502 @default.
• W1510098440 date "1992-01-01" @default.
• W1510098440 modified "2023-10-18" @default.
• W1510098440 title "Coexpression of human cAMP-specific phosphodiesterase activity and high affinity rolipram binding in yeast." @default.
• W1510098440 cites W1516147959 @default.
• W1510098440 cites W1968133040 @default.
• W1510098440 cites W1973782344 @default.
• W1510098440 cites W1974201131 @default.
• W1510098440 cites W1993182513 @default.
• W1510098440 cites W2006512568 @default.
• W1510098440 cites W2007786396 @default.
• W1510098440 cites W2008266731 @default.
• W1510098440 cites W2011876130 @default.
• W1510098440 cites W2016270023 @default.
• W1510098440 cites W2047549229 @default.
• W1510098440 cites W2069382929 @default.
• W1510098440 cites W2071331983 @default.
• W1510098440 cites W2074631079 @default.
• W1510098440 cites W2076696870 @default.
• W1510098440 cites W2148613563 @default.
• W1510098440 cites W2157724881 @default.
• W1510098440 cites W2158101364 @default.
• W1510098440 cites W2164508592 @default.
• W1510098440 cites W2952410416 @default.
• W1510098440 cites W2969273703 @default.
• W1510098440 cites W4293247451 @default.
• W1510098440 doi "https://doi.org/10.1016/s0021-9258(18)46016-4" @default.
• W1510098440 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1309798" @default.
• W1510098440 hasPublicationYear "1992" @default.
• W1510098440 type Work @default.
• W1510098440 sameAs 1510098440 @default.
• W1510098440 citedByCount "136" @default.
• W1510098440 countsByYear W15100984402015 @default.
• W1510098440 countsByYear W15100984402018 @default.
• W1510098440 countsByYear W15100984402021 @default.
• W1510098440 countsByYear W15100984402023 @default.
• W1510098440 crossrefType "journal-article" @default.
• W1510098440 hasAuthorship W1510098440A5025569634 @default.
• W1510098440 hasAuthorship W1510098440A5035784306 @default.
• W1510098440 hasAuthorship W1510098440A5039465261 @default.
• W1510098440 hasAuthorship W1510098440A5043712059 @default.
• W1510098440 hasAuthorship W1510098440A5053977112 @default.
• W1510098440 hasAuthorship W1510098440A5076338826 @default.
• W1510098440 hasAuthorship W1510098440A5078695502 @default.
• W1510098440 hasBestOaLocation W15100984401 @default.
• W1510098440 hasConcept C181199279 @default.
• W1510098440 hasConcept C185592680 @default.
• W1510098440 hasConcept C2776958096 @default.
• W1510098440 hasConcept C2779222958 @default.
• W1510098440 hasConcept C55493867 @default.
• W1510098440 hasConcept C62826618 @default.
• W1510098440 hasConcept C86803240 @default.
• W1510098440 hasConceptScore W1510098440C181199279 @default.
• W1510098440 hasConceptScore W1510098440C185592680 @default.
• W1510098440 hasConceptScore W1510098440C2776958096 @default.
• W1510098440 hasConceptScore W1510098440C2779222958 @default.
• W1510098440 hasConceptScore W1510098440C55493867 @default.
• W1510098440 hasConceptScore W1510098440C62826618 @default.
• W1510098440 hasConceptScore W1510098440C86803240 @default.
• W1510098440 hasIssue "3" @default.
• W1510098440 hasLocation W15100984401 @default.
• W1510098440 hasOpenAccess W1510098440 @default.
• W1510098440 hasPrimaryLocation W15100984401 @default.
• W1510098440 hasRelatedWork W118732687 @default.
• W1510098440 hasRelatedWork W1493920743 @default.
• W1510098440 hasRelatedWork W1979033030 @default.
• W1510098440 hasRelatedWork W1995778722 @default.
• W1510098440 hasRelatedWork W2012348315 @default.
• W1510098440 hasRelatedWork W2015572523 @default.
• W1510098440 hasRelatedWork W2034179761 @default.
• W1510098440 hasRelatedWork W2055326820 @default.
• W1510098440 hasRelatedWork W2084107544 @default.
• W1510098440 hasRelatedWork W4256220694 @default.
• W1510098440 hasVolume "267" @default.
• W1510098440 isParatext "false" @default.
• W1510098440 isRetracted "false" @default.
• W1510098440 magId "1510098440" @default.
• W1510098440 workType "article" @default.